AITRIBOND Trademark

Trademark Overview


On Tuesday, September 3, 2024, a trademark application was filed for AITRIBOND with the United States Patent and Trademark Office. The USPTO has given the AITRIBOND trademark a serial number of 79411798. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, July 29, 2025. This trademark is owned by Jiangsu Aidea Pharmaceutical Co., Ltd.. The AITRIBOND trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations for pharmaceutical purposes, namely, chemical preparations for the treatment of HIV infection; Medicines for human purposes, namely, medicines for the treatment of HIV infection; Chemico-pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of HIV infection; Drugs for medical purposes, namely, antiretroviral drugs in the form of tablet for the treatment of HIV infection; Pharmaceutical preparations, namely, antiretroviral preparations for the treatment of HIV infection; Chemical preparations for medical purposes, namely, chemical preparations for the treatment of HIV infection; Antiviral preparations, namely, antivirals for the treatment of HIV infection; Pharmaceutical preparations for the treatment of immune system-related diseases and disorders; Antiviral drugs, namely, antivirals for the treatment of HIV infection; Medicines in the form of tablets, namely, antiretroviral tablets for the treatment of HIV infection; Active pharmaceut...
aitribond

General Information


Serial Number79411798
Word MarkAITRIBOND
Filing DateTuesday, September 3, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, July 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesChemical preparations for pharmaceutical purposes, namely, chemical preparations for the treatment of HIV infection; Medicines for human purposes, namely, medicines for the treatment of HIV infection; Chemico-pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of HIV infection; Drugs for medical purposes, namely, antiretroviral drugs in the form of tablet for the treatment of HIV infection; Pharmaceutical preparations, namely, antiretroviral preparations for the treatment of HIV infection; Chemical preparations for medical purposes, namely, chemical preparations for the treatment of HIV infection; Antiviral preparations, namely, antivirals for the treatment of HIV infection; Pharmaceutical preparations for the treatment of immune system-related diseases and disorders; Antiviral drugs, namely, antivirals for the treatment of HIV infection; Medicines in the form of tablets, namely, antiretroviral tablets for the treatment of HIV infection; Active pharmaceutical ingredients (APIs), namely, antiretroviral drugs in the form of tablet for the treatment of HIV infection; Medicines for the treatment of viral diseases, namely, antiretroviral medicines for the treatment of HIV infection; Medicines for the treatment of infectious diseases, namely, antiretroviral medicines for the treatment of HIV infection.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJiangsu Aidea Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Thursday, December 12, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, December 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 12, 2024APPLICATION FILING RECEIPT MAILED
Thursday, March 6, 2025ASSIGNED TO EXAMINER
Sunday, March 30, 2025NON-FINAL ACTION WRITTEN
Monday, March 31, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 29, 2025REFUSAL PROCESSED BY MPU
Friday, May 30, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 21, 2025REFUSAL PROCESSED BY IB
Tuesday, July 29, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 29, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 29, 2025TEAS/EMAIL CORRESPONDENCE ENTERED